The anti-inflammatory properties of humic substances: A mini review
Key Findings
- Humic substances inhibit release of IL-1β, IL-6, IL-10, TNF-α and complement activation — verified from full text
- Potassium humate inhibits degranulation of phagocytes and migration/adhesion of inflammatory cells — verified
- Humic substances inhibit NF-κB activation, reducing complement receptor CR1 and CR3 expression — verified
- Potassium humate safe in humans up to 1g/kg daily; fulvic acid safe up to 1.8g per adult daily — verified
- Clinical trial: potassium humate reduced CRP levels in osteoarthritis patients (p<0.05 vs placebo) — verified
- Oxifulvic acid topically suppressed contact hypersensitivity comparable to betamethasone and diclofenac — verified
- Peat preparations used successfully for dermatitis, psoriasis, rheumatoid arthritis, and wounds — verified from Table 1
Comprehensive mini-review of the anti-inflammatory properties of humic substances, covering peat preparations, potassium humate, and fulvic acid products. Uniquely valuable because it spans preclinical mechanisms through clinical trials.
Mechanisms (verified from full text)
- Cytokine inhibition: Potassium humate inhibits IL-1β, IL-6, IL-10, TNF-α production
- Complement inhibition: Inhibits both classical and alternative complement pathways
- NF-κB inhibition: Reduces NF-κB activation in LPS-stimulated endothelial cells
- Cell adhesion: Inhibits CR1/CR3 expression, preventing inflammatory cells from adhering to blood vessel walls near inflammation sites
- Phagocyte degranulation: Inhibits release of toxic substances from phagocytes
Clinical Evidence (verified from full text)
- Potassium humate reduced CRP levels in osteoarthritis patients (double-blind placebo-controlled trial)
- Oxifulvic acid topically reduced wheel-and-flare reaction in allergic patients, comparable to hydrocortisone
- Carbohydrate-derived fulvic acid reduced skin prick test response in atopic subjects
- Tolpa peat preparation showed cardioprotective and pro-angiogenic effects in rats
Safety (verified from full text)
- Potassium humate: safe up to 1g/kg daily in humans
- Fulvic acid: safe up to 1.8g per adult daily
- No significant adverse effects reported in reviewed trials
Table 1 — Summary of successful trials
Lists preclinical and clinical applications across: peat (topical/spa for dermatitis, psoriasis, RA, wounds), sapropel (wound healing in rats), Tolpa peat (cardioprotective in rats), oxifulvic acid (eczema, contact hypersensitivity), potassium humate (allergic rhinitis, osteoarthritis).
Where this source is used on this site
Each page below cites this paper as evidence for a specific claim. The note shows what the page draws from it.
Section on fulvic acid biological activities
Brief coverage of fulvic acid antimicrobial properties
Section 3.2 — cytokine inhibition in vitro
Section 3.4 — antioxidant capacity measurements
Antioxidant properties of humic substances
Antioxidant capacity of humic substances